Achilles Therapeutics (ACHL) Short Interest Ratio & Short Volume → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free ACHL Stock Alerts $0.88 -0.02 (-2.21%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Achilles Therapeutics Short Interest DataCurrent Short Interest13,800 sharesPrevious Short Interest24,000 sharesChange Vs. Previous Month-42.50%Dollar Volume Sold Short$12,696.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares41,090,000 sharesFloat Size38,690,000 sharesShort Percent of Float0.04%Today's Trading Volume44,788 sharesAverage Trading Volume85,424 sharesToday's Volume Vs. Average52% Short Selling Achilles Therapeutics ? Sign up to receive the latest short interest report for Achilles Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACHL Short Interest Over TimeACHL Days to Cover Over TimeACHL Percentage of Float Shorted Over Time Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Achilles Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202413,800 shares $12,696.00 -42.5%0.0%0 $0.92 4/30/202424,000 shares $18,000.00 -36.5%0.1%0 $0.75 4/15/202437,800 shares $31,374.00 -49.5%0.1%0 $0.83 3/31/202474,800 shares $93,500.00 +8.6%0.2%0.1 $1.25 3/15/202468,900 shares $75,790.00 -55.2%0.2%0.1 $1.10 2/29/2024153,700 shares $202,884.00 +340.4%0.4%0.2 $1.32 Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202434,900 shares $33,497.02 +245.5%0.1%0.1 $0.96 1/31/202410,100 shares $9,393.00 -79.5%0.0%0 $0.93 1/15/202449,200 shares $43,591.20 +131.0%0.1%0.3 $0.89 12/31/202321,300 shares $18,935.70 -29.2%0.1%0.2 $0.89 12/15/202330,100 shares $26,187.00 +16.2%0.1%0.3 $0.87 11/30/202325,900 shares $21,395.99 -44.7%0.1%0.4 $0.83 11/15/202346,800 shares $37,486.80 +22.2%0.1%0.9 $0.80 10/31/202338,300 shares $32,938.00 +3.5%0.1%0.7 $0.86 10/15/202337,000 shares $33,448.00 -21.9%0.1%0.6 $0.90 9/30/202347,400 shares $43,129.26 +4.4%0.1%0.6 $0.91 9/15/202345,400 shares $40,360.60 +20.4%0.1%0.5 $0.89 8/31/202337,700 shares $34,325.85 -11.1%0.1%0.4 $0.91 8/15/202342,400 shares $41,128.00 -27.8%0.1%0.4 $0.97 7/31/202358,700 shares $59,874.00 +36.5%0.2%0.6 $1.02 7/15/202343,000 shares $42,570.00 +50.9%0.1%0.3 $0.99 6/30/202328,500 shares $26,938.20 -0.4%0.1%0.2 $0.95 6/15/202328,600 shares $28,030.86 +50.5%0.1%0.2 $0.98 5/31/202319,000 shares $19,000.00 +28.4%0.1%0.1 $1.00 5/15/202314,800 shares $14,356.00 +114.5%0.0%0.1 $0.97 4/30/20236,900 shares $5,727.00 -57.9%0.0%0 $0.83 4/15/202316,400 shares $14,596.00 +26.2%0.0%0.1 $0.89 3/31/202313,000 shares $12,447.50 +106.4%0.0%0.1 $0.96 3/15/20236,300 shares $5,827.50 -33.7%0.0%0 $0.93 2/28/20239,500 shares $10,450.00 -78.0%0.0%0 $1.10 2/15/202343,200 shares $48,384.00 +163.4%0.1%0.1 $1.12 1/31/202316,400 shares $20,336.00 -49.2%0.0%0 $1.24 1/15/202332,300 shares $38,114.00 -59.1%0.1%0.1 $1.18 12/30/202279,000 shares $71,100.00 -30.9%0.2%0.2 $0.90 12/15/2022114,300 shares $125,730.00 -9.3%0.3%0.7 $1.10 11/30/2022126,000 shares $254,520.00 +2.1%0.3%2.4 $2.02 11/15/2022123,400 shares $213,482.00 +72.4%0.3%2.5 $1.73 10/31/202271,600 shares $138,188.00 +37.4%0.2%2.7 $1.93 10/15/202252,100 shares $109,410.00 -1.1%0.1%1.9 $2.10 9/30/202252,700 shares $119,102.00 +6.3%0.1%1.6 $2.26After Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… 9/15/202249,600 shares $144,832.00 +4.2%0.1%1.4 $2.92 8/31/202247,600 shares $138,516.00 -5.0%0.1%1.2 $2.91 8/15/202250,100 shares $162,825.00 -5.8%0.1%1.2 $3.25 7/31/202253,200 shares $135,660.00 +0.6%0.1%1.1 $2.55 7/15/202252,900 shares $140,185.00 +0.8%0.1%0.9 $2.65 6/30/202252,500 shares $132,300.00 -18.7%0.1%0.5 $2.52 6/15/202264,600 shares $148,580.00 +7.1%0.2%0.6 $2.30 5/31/202260,300 shares $150,750.00 -30.0%0.2%0.5 $2.50 5/15/202286,100 shares $191,142.00 +41.9%0.2%0.8 $2.22 4/30/202260,700 shares $134,754.00 -59.8%0.2%0.6 $2.22 4/15/2022150,800 shares $357,396.00 +20.1%0.4%1.5 $2.37 3/31/2022125,600 shares $369,264.00 +114.0%0.3%1.6 $2.94 3/15/202258,700 shares $174,926.00 -2.3%0.2%1.1 $2.98 2/28/202260,100 shares $198,931.00 -19.5%0.2%0.9 $3.31 2/15/202274,700 shares $258,462.00 +3.8%0.2%1 $3.46 1/31/202272,000 shares $273,600.00 +6.2%0.2%0.6 $3.80 1/15/202267,800 shares $275,946.00 -12.4%0.2%0.5 $4.07 12/31/202177,400 shares $387,774.00 +4.5%0.2%0.4 $5.01 12/15/202174,100 shares $330,486.00 +9.9%0.2%0.3 $4.46 11/30/202167,400 shares $343,740.00 -95.3%0.2%0.3 $5.10 11/15/20211,430,000 shares $8.15 million +33.6%3.7%5.8 $5.70 10/29/20211,070,000 shares $6.57 million +21.3%2.7%3.7 $6.14 10/15/2021882,000 shares $6.71 million +15.2%2.3%3.4 $7.61 9/30/2021765,900 shares $5.97 million +29.0%2.0%3.4 $7.79 9/15/2021593,700 shares $3.45 million +1.3%1.5%4.5 $5.81 8/31/2021586,300 shares $3.98 million -0.9%1.5%4.7 $6.78 8/13/2021591,800 shares $3.82 million No Change1.5%5.2 $6.45 ACHL Short Interest - Frequently Asked Questions What is Achilles Therapeutics' current short interest? Short interest is the volume of Achilles Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 13,800 shares of ACHL short. 0.04% of Achilles Therapeutics' shares are currently sold short. Learn More on Achilles Therapeutics' current short interest. What is a good short interest percentage for Achilles Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Achilles Therapeutics' floating shares are currently sold short. Is Achilles Therapeutics' short interest increasing or decreasing? Achilles Therapeutics saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 13,800 shares, a decrease of 42.5% from the previous total of 24,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Achilles Therapeutics' float size? Achilles Therapeutics currently has issued a total of 41,090,000 shares. Some of Achilles Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Achilles Therapeutics currently has a public float of 38,690,000 shares. How does Achilles Therapeutics' short interest compare to its competitors? 0.04% of Achilles Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Achilles Therapeutics: Opthea Limited (0.19%), Cellectis S.A. (0.92%), Molecular Partners AG (0.14%), Vaxart, Inc. (10.52%), Cardiff Oncology, Inc. (10.33%), aTyr Pharma, Inc. (0.50%), Sangamo Therapeutics, Inc. (7.10%), DBV Technologies S.A. (0.54%), bluebird bio, Inc. (28.90%), Omega Therapeutics, Inc. (24.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Achilles Therapeutics stock? Short selling ACHL is an investing strategy that aims to generate trading profit from Achilles Therapeutics as its price is falling. ACHL shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Achilles Therapeutics? A short squeeze for Achilles Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHL, which in turn drives the price of the stock up even further. How often is Achilles Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHL, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OPT Short Squeeze CLLS Short Squeeze MOLN Short Squeeze VXRT Short Squeeze CRDF Short Squeeze LIFE Short Squeeze SGMO Short Squeeze DBVT Short Squeeze BLUE Short Squeeze OMGA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACHL) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.